Healthcare Services

In-Vitro Toxicology Testing Market Forecast Covering Industry Demand And Market Evolution

May 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Size Is Forecasted For The In-Vitro Toxicology Testing Market By 2030 Based On Its 2026 Value?

The in-vitro toxicology testing market has experienced significant expansion in its size over recent years. This market is projected to expand from $12.73 billion in 2025 to $14.11 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.9%. Historically, this growth can be attributed to several factors including ethical concerns over animal testing, an increase in pharmaceutical research and development activity, the early adoption of cell-based assays, regulatory restrictions on animal testing, and the growth in cosmetic safety testing.

The in-vitro toxicology testing market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $20.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.3%. This anticipated growth throughout the forecast period stems from factors such as progress in toxicogenomics and predictive modeling, a heightened need for safety testing in personalized medicine, increased capital allocation to alternative testing methods, the proliferation of regulatory guidelines that endorse in vitro techniques, and the expansion of biotechnology and biopharmaceutical product development pipelines. Key trends expected during this period involve a growing transition from in vivo to in vitro toxicology approaches, wider implementation of high-throughput screening technologies, a heightened necessity for toxicity evaluation at the early stages of drug discovery, the proliferation of cell-based and organ-on-chip assays, and an increasing embrace of alternative toxicology methods by regulatory bodies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7987&type=smp

What Primary Factors Are Fueling The Expansion Of The In-Vitro Toxicology Testing Market?

The in-vitro toxicology testing market is anticipated to be propelled by increasing healthcare expenditure. Healthcare expenditure signifies the financial resources allocated by individuals and the government from their total income towards medical facilities, at-home health services, prescription drugs, nursing homes, and personal healthcare. Global health expenditure is expanding due to the rising occurrence of diseases, which necessitates the use of in-vitro toxicology testing. For example, a report published in September 2024 by the Centers for Medicare & Medicaid Services, a federal agency based in the US, indicates that the national health expenditure (NHE) is projected to have an average growth rate of 5.6% from 2023 to 2032, surpassing the average GDP growth rate of 4.3%. Consequently, the share of health spending as a percentage of GDP is expected to increase from 17.3% in 2022 to 19.7% in 2032. Therefore, the growth in healthcare expenditure is a key driver for the in-vitro toxicology testing market.

Which Segment Groups Define The In-Vitro Toxicology Testing Market Landscape?

The in-vitro toxicology testing market covered in this report is segmented –

1) By Product And Service: Consumables, Assays, Equipment, Software, Services

2) By Technology: Cell Culture Technologies, High-throughput Technologies, Toxicogenomics

3) By Applications: Neurotoxicity, Dermal toxicity, Cytotoxicity, Other Applications

4) By Industry: Pharmaceuticals And Biopharmaceuticals, Cosmetic And Household Products, Food, Chemicals

Subsegments:

1) By Consumables: Reagents, Cell Culture Media, Plates And Vials

2) By Assays: Cell-Based Assays, Biochemical Assays, Genetic Toxicity Assays

3) By Equipment: Automated Systems, Microscopes, Plate Readers

4) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Toxicology Modeling Software

5) By Services: Testing Services, Consultation Services, Regulatory Compliance Services

What Trends Are Influencing The In-Vitro Toxicology Testing Market?

Key companies within the in-vitro toxicology testing market are adopting a strategic partnership approach to offer inhalation toxicology tests, thereby strengthening their market position. Strategic partnerships are defined as a collaborative process where companies leverage each other’s strengths and resources to achieve mutual benefits and success. For example, in November 2024, Charles River Laboratories International Inc., a US-based provider of pharmaceutical products and services, collaborated with MatTek Life Sciences, a US-based biotechnology company, to develop a new approach methodology (NAM) for inhalation toxicology testing aimed at reducing dependence on traditional animal research methods. By incorporating MatTek’s advanced 3D human tissue models into toxicology testing workflows, this initiative can bridge the divide between animal testing and human biology.

Who Are The Leading Firms Participating In The In-Vitro Toxicology Testing Market?

Major companies operating in the in-vitro toxicology testing market are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation

Access The Complete In-Vitro Toxicology Testing Market Report:

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Which Region Commands The Largest Share Of The In-Vitro Toxicology Testing Market?

North America was the largest region in the in- vitro toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access In-Vitro Toxicology Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=7987&type=smp

Browse Through More Reports Similar to the Global In-Vitro Toxicology Testing Market 2026, By The Business Research Company

Orthotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthotics-global-market-report

Prosthetics And Orthotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/prosthetics-and-orthotics-global-market-report

Orthodontic Wax Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthodontic-wax-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795